In contrast to heterozygous mutations in Fbn2 causing CCA, with contractures and muscle weakness, results in mice predict that homozygous Fbn2 mutations may cause a form of human congenital muscular dystrophy. The gene discussed is FBN2; the disease is congenital contractural arachnodactyly.